Hedge Fund and Insider Trading News: Bill Ackman, Ken Griffin, Cathie Wood, Dan Sundheim, Tiger Global Management, Aurelius Capital Management, Tarsus Pharmaceuticals Inc (TARS), Appian Corporation (APPN), and More

North Rock Capital opens first office in Asia (Hedge Week)
North Rock Capital Management LLC, the US hedge fund ($3 billion AuM) is opening its first Asian office in Hong Kong, according to a report from Bloomberg. The hedge fund has opted not to follow suit, despite years of political unrest and Covid-19 restrictions in the city, and has recruited former Credit Suisse prime broker, Simon Chow, to lead the new project.

What Cramer is Watching Tuesday — David Tepper Makes a Big Call, Cathie Wood Under Fire (CNBC)
What I am looking at May 10, 2022: Watching the collapse of the Cathie Wood stocks and the remarkable insistence to keep buying them endlessly. They are at the heart of the blast zone and even though the Ark Invest CEO is running an active ETF, she is being shot against every day by sellers and short-sellers. I know what it is like to be shot against even though I wasn’t running an ETF. Enough with the decision to call it something other than a hedge fund.

Hedge Fund Aurelius Moves Headquarters to South Florida From NYC (Bloomberg)
Hedge fund Aurelius Capital Management has moved its headquarters to South Florida from New York, joining the wave of finance firms that have either relocated or expanded to the Sunshine State during the pandemic. Aurelius now lists its address as 3825 PGA Blvd. in Palm Beach Gardens, according to filings with the U.S. Securities and Exchange Commission. As recently as this year, the hedge fund reported it was based at 535 Madison Ave. in Manhattan.

Tuesday 5/10 Insider Buying Report: TARS (Nasdaq.com)
On Thursday, Director Michael Ackermann purchased $1.35M worth of Tarsus Pharmaceuticals, purchasing 100,000 shares at a cost of $13.50 a piece. This purchase marks the first one filed by Ackermann in the past year. Tarsus Pharmaceuticals is trading up about 3.8% on the day Tuesday. Bargain hunters can grab TARS at a price even lower than Ackermann did, with the stock trading as low as $11.43 at last check today which is 15.3% below Ackermann’s purchase price.

Executives Buy Around $141M Of 4 Stocks (Benzinga)
Appian: The Trade: Appian Corporation (APPN) 10% owner Appian acquired a total of 784,538 shares at at an average price of $45.13,. To acquire these shares, it cost around $35.4 million. Kymera Therapeutics: The Trade: Kymera Therapeutics, Inc. (KYMR) Director Mark Lampert acquired a total of 250,000 shares at an average price of $19.46. To acquire these shares, it cost around $4.87 million.

Follow Insider Monkey on Twitter